| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| R&D Expense | — | — | — | — |
| SG&A Expense | — | — | — | — |
| Operating Income | — | — | — | — |
| Net Income | $1.3B | $1.5B | $1.5B | $0.6B |
| EPS (Basic) | $1.86 | $2.44 | $2.75 | $1.21 |
| EPS (Diluted) | $1.86 | $2.44 | $2.68 | $1.19 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Total Assets | $31.2B | $28.3B | $23.8B | $22.4B |
| Current Assets | — | — | — | — |
| Cash & Equivalents | $0.6B | $0.6B | $0.5B | $0.3B |
| Total Liabilities | $16.9B | $14.9B | $12.6B | $12.8B |
| Current Liabilities | — | — | — | — |
| Stockholders' Equity | $14.3B | $13.4B | $11.2B | $9.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Operating Cash Flow | $-1.7B | $-2.1B | $0.5B | $-1.4B |
| Investing Cash Flow | — | — | — | — |
| Capital Expenditures | — | — | — | — |
| Financing Cash Flow | $1.8B | $2.4B | $-0.3B | $1.2B |